two cells

The Cell Response and Regulation (CRR) Program’s research provides new insights into basic mechanisms and cancer pathways that may have clinical applications:

  • Target identification
  • Chemoprevention
  • Drug discovery
  • Biomarker development

The CRR Program works to decipher cellular mechanisms involved in cancer in these theme areas:

  • Cell turnover, including control and dysregulation of cell division and cell death, as well as stem cell biology and its role in tumor-initiating cells
  • Aberrant signaling in cancer, including mechanisms of drug resistance
  • Mechanisms involved in metastasis, including cell motility in cancer

Program Membership

HCI Cancer Center members enjoy a variety of benefits, including eligibility for leadership roles in the Center, institutional funding opportunities, and scientific/administrative support.

News Highlights from the Cell Response and Regulation Program

Together We Care Compassionately
Mar 01, 2019

Together We Care Compassionately

Approximately 500 patients visit the outpatient clinics and infusion center at Huntsman Cancer Institute each day. Our patients rely on our clinical teams and staff to provide safe, efficient, and high quality care during each clinic visit. In this letter from Don Milligan, director of outpatient services, highlights recent efforts to provide the best care possible.... Read More

Huntsman Cancer Institute Breaks Ground for Utah’s First Proton Therapy Center
Nov 20, 2018

Huntsman Cancer Institute Breaks Ground for Utah’s First Proton Therapy Center

Officials at Huntsman Cancer Institute at the University of Utah began construction on a project that will house the region’s first proton therapy center and announced the new center will be named in honor of United States Senator Orrin G. Hatch. Cancer patients and loved ones joined leaders from HCI, Huntsman Cancer Foundation, and the university to mark the occasion. ... Read More

Lung Cancer Research Foundation Awards $1.95 Million in Research Grants
Nov 01, 2018

Lung Cancer Research Foundation Awards $1.95 Million in Research Grants

The Lung Cancer Research Foundation (LCRF) announced the awardees of its 2018 Scientific Grant Program today during the Thirteenth Annual Lung Cancer Awareness Luncheon, held at The Pierre in New York City. Through this program, LCRF awarded $1.95 million in research grants to 13 investigators for innovative research focused on the prevention, diagnosis, and treatment of lung cancer. LCRF received a record-breaking 201 grant applications, representing 116 institutions and 21 countries in 2018. ... Read More

A Bad Influence: The Interplay between Tumor Cells and Immune Cells
Oct 16, 2018

A Bad Influence: The Interplay between Tumor Cells and Immune Cells

Research at Huntsman Cancer Institute at the University of Utah yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment. The results were published today in Immunity and featured on the print cover of the journal. ... Read More

Read More